Current Edition

Europe

Lynparza shows benefits in prostate cancer

Lynparza (olaparib) continues to go from strength to strength, as the MSD and AstraZeneca PARP inhibitor has now been shown to slow or stop tumour growth in some men...
Continue Reading →
news

Merck’s Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?

Currently, five PD-1/L1 inhibitors boast FDA approvals to treat certain bladder cancer patients. But only one of them is about to enter a different segment of the di...
Continue Reading →
Europe

Hypha Discovery announces “One-Stop Metabolite Shop” solution to support pharmaceutical and agrochemical R&D

 Hypha Discovery Limited, a leading specialist CRO, has launched its “One-Stop Metabolite Shop” to provide a complete solution for provision of small molecule drug m...
Continue Reading →
Europe

IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies for novel cancer targets

IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has entered into a collaboration agreement with Ada...
Continue Reading →
Europe

Clinerion and Massive Bio partner to improve cancer patient lives

Clinerion, provider of the Patient Network Explorer platform which harnesses patient data from a global hospital network, and Massive Bio, provider of end-to-end pa...
Continue Reading →
news

Unique Alzheimer’s Disease Tau Vaccine Shows Great Potential in Pre-Clinical Studies

MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice Capo Therapeutics, I...
Continue Reading →
news

TSI Reports Enrollment of First 10 Patients in its Phase 2 Ischemic Stroke Clinical Trial and Completion of its Phase 2 Study Protocol in Myocardial Infarction

Studies Aim to Confirm Safety and Efficacy of Novel Bio-inspired Clot-dissolving Therapy Thrombolytic Science, LLC (TSI) today announced progress with 10 patients ...
Continue Reading →
Asia Pacific

Clinerion partners with PPC to bring Patient Network Explorer coverage and services to patients and hospitals in Korea, China and Taiwan

PPC will offer Patient Network Explorer services for accelerating clinical trial site selection and recruitment in Korea, China and Taiwan. PPC will support Cliner...
Continue Reading →
Europe

New evidence links 1970s pregnancy test drug to life-changing birth defects

There may have been a 'cover-up' of the effect of the drug on pregnant mothers, say campaigners. New evidence has emerged linking the hormone-based drug Primodos ...
Continue Reading →
Europe

Clovis’ Rubraca, trailing PARP rivals, nabs England coverage thanks to NICE U-turn

Already behind in the PARP inhibitor race, Clovis Oncology’s Rubraca has won a boost with reserved backing from England’s drug cost watchdog that helps level th...
Continue Reading →